Abstract
The study was concerned with the influence of single dose of estradiol dipropionate on its promoting effect on 1,2-dimethylhydrazine-induced tumors in female CBA/CaLac mice. Estradiol dipropionate given within 19 weeks did not affect carcinogenesis whereas 39-week treatment stimulated uterine sarcoma development irrespective of single dose and schedule of administration.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
1,2-Dimethylhydrazine
-
Alleles
-
Animals
-
Carcinogens
-
Cocarcinogenesis*
-
Dimethylhydrazines / toxicity*
-
Estradiol / analogs & derivatives*
-
Estradiol / toxicity
-
Female
-
Genotype
-
Methylhydrazines / toxicity*
-
Mice
-
Mice, Inbred CBA / genetics
-
Sarcoma, Experimental / chemically induced*
-
Sarcoma, Experimental / epidemiology
-
Time Factors
-
Uterine Neoplasms / chemically induced*
-
Uterine Neoplasms / epidemiology
Substances
-
Carcinogens
-
Dimethylhydrazines
-
Methylhydrazines
-
Estradiol
-
1,2-Dimethylhydrazine
-
estradiol dipropionate